Unlike many other hematological or solid tumors, acute leukemias, including Acute Myeloid Leukemia (AML), do not have a formal staging system. This is because these diseases typically have a rapid onset and aggressive progression, making traditional staging methods less relevant for treatment planning or prognosis.